triiodothyronine has been researched along with fulvestrant in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dipippo, VA; Powers, CA | 1 |
| Hall, LC; Kane, SR; Liu, N; Salazar, EP | 1 |
1 review(s) available for triiodothyronine and fulvestrant
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for triiodothyronine and fulvestrant
| Article | Year |
|---|---|
Tamoxifen and ICI 182,780 interactions with thyroid hormone in the ovariectomized-thyroidectomized rat.
Topics: Animals; Body Weight; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Malate Dehydrogenase; Organ Size; Ovariectomy; Rats; Receptors, Estrogen; Receptors, Thyroid Hormone; Tamoxifen; Thyroidectomy; Triglycerides; Triiodothyronine; Uterus | 1997 |
Effects of thyroid hormones on human breast cancer cell proliferation.
Topics: Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Female; Fulvestrant; Gene Expression; Genes, Reporter; Humans; Luciferases; Thyroid Hormone Receptors beta; Triiodothyronine | 2008 |